Webest Multi-Drug Urine Cup; Webest Home Multi-Drug Urine Cup
WEBEST Biotech,, LLC · Decision date Mar 9, 2026
What did the FDA decide?
FDA records K260355 as a 510(k) premarket notification, with a decision dated Mar 9, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Toxicology
- Decision date
- Mar 9, 2026
Regulatory record facts
- Identifier
- K260355
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- WEBEST Biotech,, LLC
- Product code
- NFT
- Decision code
- SESE
- Decision date
- Mar 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Test, Amphetamine, Over The Counter.
- Applicant
- WEBEST Biotech,, LLC
- Product code
- NFT
- FDA device class
- 2
FDA decision timeline
K260355 received
Application receipt date recorded by FDA.
K260355 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NFT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bioteke Corporation (Wuxi) Co., Ltd. | 510(k) clearance | Sep 10, 2026 | FDA | |
| Assure Tech., LLC | 510(k) clearance | Jul 17, 2026 | FDA | |
| Vivachek Biotech (Hangzhou) Co., Ltd. | 510(k) clearance | May 22, 2026 | FDA | |
| GUANGZHOU WONDFO BIOTECH CO., LTD. | 510(k) clearance | Apr 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
WEBEST Biotech,, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Irwindale, CA
Sources and methodology
- Original FDA record: K260355
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

